This study consisted of three back injury subjects, who used the DAVID Paradise to treat their chronic pain. They measured pain, medication used, suicide ideation, anxiety, self-esteem, hopefulness, coping ability and family stability. The results were very encouraging. One subject was taking up to 35 Extra Strength Tylenol with codeine per day before treatment and experiencing a subjective pain level of "7" out of "9". After one year of AVE, he was down to two or less Tylenol daily and reported a subjective pain level of "2."

This purpose of this study was to determine the effectiveness of the "Relaxodont" during endodontic (root canal) procedures. Galvanic skin response, heart rate and anxiety levels were recorded during all aspects of the root canal. Data was recorded from three groups: a control group (no stimulation), white-light audio-visual entrainment only, and white-light entrainment and music. The study concluded that audio-visual entrainment was an effective method of maintaining relaxation during root-canal procedures.

This study used the DAVID Paradise to treat chronic pain. Of the twelve participants who completed the study, most had pain due to fibromyalgia, lupus, arthritis, TMJ Dysfunction and/or motor vehicle accidents. After eight weeks of treatment, the Visual Analogue Pain Scale showed a reduction in the pain to the p<0.005 level and the Beck Depression Index showed improvements to the p<0.05 level. This study shows the benefit of using AVE in the treatment of chronic pain. A subsequent study is currently in progress.

During the 1998/99 winter, we completed a 74 person study on SAD. Depression as measured on the Beck Depression Inventory (BDI) was reduced in 100% of the participants, falling from an average pre-test score of 20.5 to a non-depressed 7.3. Depression was completely eliminated in 84% of those in the AVE group while the control group depression increased. 84% of females and 100% of the males also had no clinical anxiety by the end of treatment. There also were improvements in mood, leading to improved family, work and social life. AVE could be an excellent way to prevent winter-time weight gain. Over-eating and carbohydrate cravings were reduced, energy increased and the participants lost an average of 9.5 lbs!

FMS is dominant primarily in women (3-5%). FMS is characterized by physical symptoms of muscle pain, chronic fatigue and non-restful (alpha) sleep. Most sufferers of FMS experience depression (>70%), anxiety (24%) and cognitive problems of "Fibro-fog" (a slow alpha brainwave condition).

Three groups totaling 49 participants were randomly selected and placed into an AVE, medical treatment or nutrition group. Participants were taken from Dr. Seibel's patient list. During the first month all participants received individual treatments and during the second month, received all treatments combined. Participants were assessed on a SCL-90 personality test. The AVE group showed better improvements than the medical and nutritional groups (see graph). Participants used the AVE as follows; 1) Delta stimulation at bedtime for sleep; 2) Alpha sessions in the afternoon - for anxiety, and; 3) Beta sessions upon awakening - for a clear mind.